The cardiovascular continuum refined: A hypothesis

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Blood Pressure

• Publication date

  2010-09-21

• Fields of study

  Medicine

• Identifiers
  DOI 10.3109/08037051.2010.481072PMID 20446877
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• BNP-guided vs symptom-guided heart failure therapy: the Trial of Intensified vs Standard Medical Therapy in Elderly Patients With Congestive Heart Failure (TIME-CHF) randomized trial.

  2009cited by this paper
• Irbesartan in patients with heart failure and preserved ejection fraction.

  2008cited by this paper
• Association of heart rate with microalbuminuria in cardiovascular risk patients: data from I-SEARCH

  2008cited by this paper
• Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein.

  2008cited by this paper
• Prognosis of heart failure with preserved ejection fraction: a 5 year prospective population-based study.

  2008cited by this paper
• Reduced incidence of new-onset atrial fibrillation with angiotensin II receptor blockade: the VALUE trial

  2008cited by this paper
• FASTTRACK : The perindopril in elderly people with chronic heart failure (PEP-CHF) study

  2006cited by this paper
• Multiple biomarkers for the prediction of first major cardiovascular events and death.

  2006cited by this paper
• Rationale and design of ACTIVE: the atrial fibrillation clopidogrel trial with irbesartan for prevention of vascular events.

  2006cited by this paper
• Fewer mega-trials and more clinically oriented studies in hypertension research? The case of blocking the renin-angiotensin-aldosterone system.

  2006cited by this paper
• Cardiovascular proteomics: tools to develop novel biomarkers and potential applications.

  2006cited by this paper
• New Definition of Microalbuminuria in Hypertensive Subjects: Association With Incident Coronary Heart Disease and Death

  2005cited by this paper
• Cardiovascular morbidity and mortality in hypertensive patients with a history of atrial fibrillation: The Losartan Intervention For End Point Reduction in Hypertension (LIFE) study.

  2005cited by this paper
• Angiotensin II receptor blockade reduces new-onset atrial fibrillation and subsequent stroke compared to atenolol: the Losartan Intervention For End Point Reduction in Hypertension (LIFE) study.

  2005cited by this paper
• Reduction in Albuminuria Translates to Reduction in Cardiovascular Events in Hypertensive Patients: Losartan Intervention for Endpoint Reduction in Hypertension Study

  2005cited by this paper
• CDC/AHA Workshop on Markers of Inflammation and Cardiovascular Disease: Application to Clinical and Public Health Practice: ability of inflammatory markers to predict disease in asymptomatic patients: a background paper.

  2004cited by this paper
• Antiinflammatory Effects of Angiotensin II Subtype 1 Receptor Blockade in Hypertensive Patients With Microinflammation

  2004cited by this paper
• Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial.

  2003cited by this paper
• Is it time to measure microalbuminuria in hypertension?

  2003cited by this paper
• Clinical application of C-reactive protein for cardiovascular disease detection and prevention.

  2003cited by this paper
• N‐Terminal Pro‐Brain Natriuretic Peptide and Other Risk Markers for the Separate Prediction of Mortality and Subsequent Myocardial Infarction in Patients With Unstable Coronary Artery Disease: A Global Utilization of Strategies To Open occluded arteries (GUSTO)‐IV Substudy

  2003cited by this paper
• The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes.

  2001cited by this paper
• Perindopril for elderly people with chronic heart failure: the PEP‐CHF study

  1999cited by this paper
• Independent risk factors for atrial fibrillation in a population-based cohort. The Framingham Heart Study.

  1994cited by this paper

• The relationship between metabolic hormone levels and the prevalence of hypertension in people under 45 years of age

  2025cites this paper
• A machine learning analysis of predictors of future hypertension in a young population.

  2024cites this paper
• Medical expenditure and its influencing factors of patients with hypertension in Shanxi Province, China: a study based on ‘System of Health Accounts 2011’ and multiple-layer perceptron neural network

  2022cites this paper
• ARB-Based Combination Therapy for the Clinical Management of Hypertension and Hypertension-Related Comorbidities: A Spotlight on Their Use in COVID-19 Patients

  2021cites this paper
• Cardiometabolic Risk Reduction: A Review of Clinical Guidelines and the Role of SGLT-2 Inhibitors.

  2021cites this paper
• Drug adjustment of modified risk factors as one of the leading strategies for managing patients with cardiovascular diseases

  2020cites this paper
• An Analysis of Economic Burden of Hypertensive Patients Based on “System of Health Accounts 2011” and Multiple Layer Perceptron Neural Network

  2020cites this paper
• Time Trend Analysis of Hypertension Prevalence, Awareness, Treatment and Control in Italy: Novel Insights from Recent National Surveys in the General Population

  2017cites this paper
• A Central Role for Monocyte–Platelet Interactions in Heart Failure

  2016cites this paper
• Hypertension in Young People: Epidemiology, Diagnostic Assessment and Therapeutic Approach

  2015cites this paper
• Endocan, a novel marker of endothelial dysfunction in patients with essential hypertension: Comparative effects of amlodipine and valsartan

  2015cites this paper
• [Detection of left ventricular hypertrophy during the assessment of cardiovascular risk in hypertensive patients].

  2014cites this paper
• Genetics of melatonin receptor type 2 is associated with left ventricular function in hypertensive patients treated according to guidelines.

  2013cites this paper